Walgreens Boots Alliance reported its Q2 earnings, with an adjusted EPS of $1.20, beating expectations of $0.82, and revenue of $37.05 billion, exceeding the forecast of $35.86 billion. The company narrowed its FY adjusted EPS guidance to $3.20-$3.35 from the previous $3.20-$3.50. Walgreens took a $5.8 billion impairment charge related to its investment in VillageMD, resulting in a significant loss for the quarter. The company also announced plans to cut costs by $1 billion this year.